Castle Biosciences share price logo

Castle Biosciences

NASDAQ: CSTL

Small Cap

$33.99

-0.43

(-1.25%)

as on

Castle Biosciences Stock Performance

as on November 12, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $33.82
    $35.48
    downward going graph

    0.50%

    Downside

    4.38%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $17.72
    $44.28
    downward going graph

    47.86%

    Downside

    30.27%

    Upside

    downward going graph

Castle Biosciences share price movements today

Previous Close
$34.42
Open
$35.01
Volume
399.2K
Market Cap
$1.1B
Day's Low - High
$33.82 - $35.48
52 Week Low - High
$17.72 - $44.28

Castle Biosciences Historical Returns

1 Month Return
+ 3.75 %
3 Month Return
+ 8.15 %
1 Year Return
-2.38 %
3 Year Return
+ 97.85 %
5 Year Return
-34.23 %

Castle Biosciences Stock Fundamentals & Key Indicators

Check Castle Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-0.7695

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.52%

PE Ratio (TTM)

-44.73

Industry PE ratio

-6.38

PEG Ratio

0.45

EBITDA

-6.1M

Revenue (TTM)

377.1M

Profit Margin

77.07%

Return On Equity TTM

-4.89%

Castle Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Castle Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Castle Biosciences image
Castle Biosciences
StrongBuy$1.1B-34.23%-44.7377.07%0.00%
Idexx Laboratories image
Idexx Laboratories
Buy$54.9B11.85%46.9862.72%0.00%
Agilent image
Agilent
StrongBuy$50.1B9.99%34.9553.73%0.57%
Thermo Fisher image
Thermo Fisher
StrongBuy$266.1B12.98%37.8241.44%0.26%
Danaher image
Danaher
StrongBuy$166.1B-22.69%38.5858.59%0.64%

Stock Returns calculator for Castle Biosciences Stock including INR - Dollar returns

The Castle Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Castle Biosciences investment value today

Current value as on today

₹1,03,622

Returns

₹3,622

(+3.62%)

Returns from Castle Biosciences Stock

-₹2,384 (-2.38%)

Dollar Impact

₹6,005 (+6.01%)

Analyst Recommendation on Castle Biosciences Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Castle Biosciences. Average target price of $47.4

Castle Biosciences Share Price Target

Get share price movements and forecasts by analysts on Castle Biosciences.

What analysts predicted

28.29%UPSIDE

Target Price

$47.4

Current Price

$33.99

Analyzed by

7 Analysts

High

$60

Target

$47.40

Low

$39

Castle Biosciences target price $47.4, a slight upside of 28.29% compared to current price of $33.99. According to 7 analysts rating.

Indian Investors' Interest in Castle Biosciences Stock

Search interest for Castle Biosciences Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Castle Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
87
85
86
87
86
83
87
83
103
102
Gross Profit
72
70
70
71
68
64
68
63
79
78
Operating Income
5
5
4
-27
-4
-6
-3
-18
-3
-2
EBITDA
11
12
13
3
3
3
1
-10
2
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
3
3
5
29
3
3
3
3
4
4
Income Before Tax
7
8
7
-26
0
0
-2
-14
-1
-3
Income Tax Expense
-1
6
-1
0
-4
0
0
0
0
0
Net Income
8
2
9
-25
4
0
-2
-14
-2
-4
Net Profit Margin
83.31%
81.80%
81.25%
81.38%
79.55%
77.48%
78.95%
75.46%
77.11%
76.75%

Castle Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
13
22
51
62
94
137
219
332
344
Gross Profit
8
17
44
52
78
105
174
271
273
Operating Income
-10
-3
7
-6
-40
-72
-67
8
-42
EBITDA
-10
-3
10
-7
-36
-58
-45
38
11
Interest Expense
1
2
4
2
0
0
0
0
0
Depreciation
0
0
0
0
3
10
12
15
40
Income Before Tax
-12
-6
5
-10
-40
-68
-57
21
-29
Income Tax Expense
0
0
0
0
-8
-1
0
3
-5
Net Income
-12
-6
5
-10
-31
-67
-57
18
-24
Net Profit Margin
64.21%
76.75%
85.91%
84.54%
83.18%
76.64%
79.53%
81.87%
79.37%

Castle Biosciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
8
2
9
-25
4
0
-2
-14
-2
-4
Operating Cash Flow
23
23
24
-6
20
22
26
-22
15
19
Investing Cash Flow
-21
-14
5
-22
-28
-18
8
-25
-15
-4
Financing Cash Flow
0
0
-5
-1
0
0
-4
-5
0
0
Change in Cash
2
9
24
-30
-7
3
31
-52
-1
15

Castle Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-6
5
-10
-31
-67
-57
18
-24
Operating Cash Flow
-12
-12
7
9
-18
-41
-5
64
64
Investing Cash Flow
0
0
0
-4
-66
-166
-16
-50
-60
Financing Cash Flow
8
15
88
305
5
1
-2
6
-6
Change in Cash
-3
3
94
311
-80
-206
-24
20
-2

Global Institutional Holdings in Castle Biosciences

Check out the Institutions with significant holdings in Castle Biosciences.

Funds
Holdings
BlackRock, Inc.
10.68%
COLUMBIA FUNDS SERIES TRUST I
7.40%
iShares
5.74%
Vanguard
4.86%
VANGUARD INDEX FUNDS
3.88%
See all

Castle Biosciences News & Key Events

  • img

    Today's Timeline - 09 November

    Mon, 04:50 PM

    -

    Castle Biosciences raises 2026 revenue outlook to $385M-$395M following strong Q3 results.

    Tue, 02:00 AM

    -

    BTIG raises Castle Biosciences price target to $52, citing positive Q3 performance and Medicare coverage expectations.

Insights on Castle Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, CSTL stock has moved up by 82.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CSTL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Thermo Fisher Scientific, Inc. has given 22.1% return, outperforming this stock by 24.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 103.54M → 102.89M (in $), with an average decrease of 0.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -2.06M → -4.1M (in $), with an average decrease of 99.0% per quarter

About Castle Biosciences

Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with invasive cutaneous melanoma. In addition to their leading solution, the company has created several other specialized, proprietary tests. Among these is DecisionDx-UM, a GEP test tailored to forecast the risk of metastasis for individuals with uveal melanoma, a less common malignancy of the eye. Another key offering is DecisionDx-SCC, a distinctive 40-gene expression profile test that utilizes a patient's unique tumor biology to predict their specific risk of squamous cell carcinoma metastasis, particularly for those presenting with recognized risk factors. Moreover, they offer DecisionDx DiffDx-Melanoma and myPath Melanoma, both proprietary GEP tests employed to assist in the accurate diagnosis of ambiguous pigmented lesions. These specialized testing services are provided by Castle Biosciences to patients predominantly through their healthcare providers. The organization commenced operations in 2007 and maintains its corporate headquarters in Friendswood, Texas.
OrganisationCastle Biosciences
Headquarters1500 W. Parkwood Ave, Friendswood, TX, 77546, US
IndustryMedical - Diagnostics & Research
CEODerek J. Maetzold

Key Management of Castle Biosciences

Name

Title

Mr. Frank Stokes

CFO & Treasurer

Ms. Kristen M. Oelschlager R.N.

Chief Operating Officer

Ms. Camilla Zuckero

Vice President of Investor Relations & Corporate Affairs

Dr. Jay Braxton Pharm.D.

Senior Vice President of Marketing

Dr. Matthew Goldberg M.D.

Senior Vice President of Medical

Ms. Trisha Poteet

Senior VP of Clinical Services & Manufacturing Operations

Mr. Derek J. Maetzold

Founder, CEO, President & Director

Mr. Tobin W. Juvenal

Chief Commercial Officer

Mr. Kevin Doman

Senior Vice President of Sales

Ms. Keli Greenberg

Vice President of Human Resources

FAQs

What is Castle Biosciences share price today?

Castle Biosciences share price today is $33.99 as on at the close of the market. Castle Biosciences share today touched a day high of $35.48 and a low of $33.82.

What is the 52 week high and 52 week low for Castle Biosciences share?

Castle Biosciences share touched a 52 week high of $44.28 on and a 52 week low of $17.72 on . Castle Biosciences stock price today i.e. is closed at $33.99,which is 23.24% down from its 52 week high and 91.80% up from its 52 week low.

What is Castle Biosciences's market capitalisation today?

Castle Biosciences market capitalisation is $0.00T as on .

How to invest in Castle Biosciences Stock (CSTL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Castle Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Castle Biosciences Stock (CSTL) from India?

Indian investors can start investing in Castle Biosciences (CSTL) shares with as little as ₹94.04000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.40 in Castle Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Castle Biosciences share’s latest price of $33.99 as on November 12, 2026 at 8:45 am IST, you will get 0.2942 shares of Castle Biosciences. Learn more about fractional shares .

What are the returns that Castle Biosciences has given to Indian investors in the last 5 years?

Castle Biosciences stock has given -34.23% share price returns and 26.34% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?